VIENNA–Ribbon Bio GmbH, the DNA synthesis company, announced today that John Luckey, Ph.D. has been appointed Chief Technology Officer. Dr. Luckey brings more than 25 years of technology development leadership experience in both start-up and global companies, advancing platforms and systems used in biomedical research and translational medicine, most recently at DNA Script. “We are […]
BOSTON and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D., as a director with an initial term expiring at Avantor’s 2025 Annual Meeting of Stockholders. […]
The Ultra-Processive UltraMarathonRT Kit Enables Consistent, Robust Amplification of Long RNAs in 80 Minutes with Very Low RNA Input. Branford, CT – RNAConnect, a pioneering life science reagent company, today announced the launch of the UltraMarathonRT® Two-Step RT-PCR Kit, a next-generation solution for researchers conducting RNA-to-cDNA conversion and amplification experiments. Designed for enhanced processivity, sensitivity, and fidelity, […]
BOSTON, United States and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today announced that Ross Muken, previously Chief Financial Officer (“CFO”) and Chief Operating Officer (“COO”), has been promoted to company President, effective November 5, 2024. George Cardoza has been appointed as the company’s new CFO. […]
New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore designed to: Advance biomedical research and translate discoveries for improved patient care Improve health outcomes by targeting novel genomic and epigenomic discoveries in cancer, human genetic disease and infectious disease Initial programme: to create an ‘early warning system’ for future pandemics across […]
Complete Genomics Highlights Innovation with Expanded Multi-Omics and Spatial Transcriptomics Applications at ASHG 2024 Complete Genomics Highlights Innovation with Expanded Multi-Omics and Spatial Transcriptomics Applications at ASHG 2024 DENVER – At the American Society of Human Genetics (ASHG) Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highlight an expanded application […]
SALT LAKE CITY and OXFORD, United Kingdom — Wasatch Biolabs (WBL), a disruptive R&D and high-throughput clinical laboratory, today announced a collaboration with Oxford Nanopore Technologies (ONT), the company delivering a new generation of nanopore-based molecular sensing technology, to develop a Direct Whole Methylome Sequencing product that addresses key limitations associated with traditional bisulfite sequencing and methylation microarrays. […]
New, groundbreaking technology delivers Illumina’s mostcomprehensive genome yet; early results from Broad Clinical Labs demonstrate a highly simplified workflow, ultra-long phasing, high-resolution insights into complex genomic variation,and enhanced long-range information Illumina and customers will also showcase new details on complete proteomics solution and latest data on Fluent single-cell technology SAN DIEGO — Illumina, Inc. […]
SAN DIEGO — Inocras, a leader in whole genome sequencing (WGS) and bioinformatics, has introduced MRDVision, a minimal residual disease (MRD) detection solution showcasing a limit of detection (LOD) down to one-in-a-million. MRDVision combines Inocras’s WGS cancer profiling platform, CancerVision, and Ultima Genomics’ ppmSeq™ technology to deliver high-accuracy detection of circulating tumor DNA. This assay […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
